Muted reception for Sensei, Landos on NASDAQ as more biotechs set to leap into public markets

While Sana’s massive IPO drew most of the attention among new listings Thursday, biotechs Sensei and Landos made quieter NASDAQ debuts, with several more companies set to price for Friday’s session.

Sensei Biotherapeutics Inc. (NASDAQ:SNSE) gave back early double-digit gains to settle near its offering price, finally dipping $0.10 to $18.90 at close. The Gaithersburg, Md.-based developer of bacteriophage-derived treatments for cancer had bumped up its share count and priced above its proposed range...